Resalis Begins Phase 1 Trial for RES-010 in Obesity
03 Dec 2024 //
BUSINESSWIRE
Resalis Therapeutics Gains Strategic Equity Investment from Sanofi
28 Oct 2024 //
BUSINESSWIRE
Resalis Appoints Almut Nitsche as Chief Medical and Development Officer
01 Feb 2024 //
BUSINESSWIRE
Resalis Therapeutics Raises €10 Million Series A
04 Jan 2024 //
BUSINESSWIRE